Target Name: ANO2
NCBI ID: G57101
Review Report on ANO2 Target / Biomarker Content of Review Report on ANO2 Target / Biomarker
ANO2
Other Name(s): transmembrane protein 16B (eight membrane-spanning domains) | OTTHUMP00000238430 | anoctamin 2, calcium activated chloride channel | anoctamin 2 | ANO2 variant 1 | Anoctamin-2 | C12orf3 | Anoctamin 2, transcript variant 1 | Transmembrane protein 16B (eight membrane-spanning domains) | TMEM16B | Anoctamin 2, calcium activated chloride channel | Anoctamin 2 | Anoctamin-2 (isoform 1) | DKFZp434P102 | ANO2_HUMAN | Transmembrane protein 16B

ANO2: A Transmembrane Protein Involved in Cell Signaling and Tissue Maintenance

ANO2, or transmembrane protein 16B, is a protein that is expressed in various tissues throughout the body. It plays a critical role in the regulation of cell signaling pathways, and is a key player in the development and maintenance of tissues such as the brain, heart, and kidneys.

ANO2 is a four-domain transmembrane protein that consists of an N-terminal transmembrane domain, a protein transmembrane domain, a C-terminal transmembrane domain, and an V-terminal cytoplasmic domain. The N-terminal transmembrane domain is responsible for the formation of the protein's transmembrane region, while the C-terminal and V-terminal domains are involved in the regulation of the protein's stability and localization to different cell types.

One of the unique features of ANO2 is its eight membrane-spanning domains. These domains are arranged in a repeating pattern of two parallel beta-helices, which form the basis of the protein's transmembrane structure. The eight membrane-spanning domains give ANO2 its unique 8-fold repeat structure, and are involved in the regulation of the protein's stability and localization to different cell types.

ANO2 is involved in a wide range of physiological processes in the body, including the regulation of cell signaling pathways, the development and maintenance of tissues, and the regulation of ion and water transport. It is well established that ANO2 plays a critical role in the development and maintenance of the brain, heart, and kidneys, and is involved in the regulation of a wide range of physiological processes that are critical for human health and survival.

Despite the importance of ANO2 in human health, the development of effective therapies for ANO2-related diseases remains a major challenge. Currently, there are limited treatment options available for diseases that are characterized by the dysfunction or dysfunctional regulation of ANO2.

In conclusion, ANO2 is a transmembrane protein that is involved in a wide range of physiological processes in the body. Its eight membrane-spanning domains give it a unique structure that is involved in the regulation of cell signaling pathways, and its critical role in the development and maintenance of tissues makes it an attractive target for future therapies. Further research is needed to develop effective treatments for ANO2-related diseases.

Protein Name: Anoctamin 2

Functions: Calcium-activated chloride channel (CaCC) which may play a role in olfactory signal transduction. Odorant molecules bind to odor-sensing receptors (OSRs), leading to an increase in calcium entry that activates CaCC current which amplifies the depolarization of the OSR cells, ANO2 seems to be the underlying chloride channel involved in this process. May mediate light perception amplification in retina

The "ANO2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANO2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ANO3 | ANO4 | ANO5 | ANO6 | ANO7 | ANO7L1 | ANO8 | ANO9 | Anoctamin | ANOS1 | ANOS2P | ANP32A | ANP32A-IT1 | ANP32AP1 | ANP32B | ANP32C | ANP32D | ANP32E | ANPEP | ANTKMT | ANTXR1 | ANTXR2 | ANTXRL | ANTXRLP1 | ANXA1 | ANXA10 | ANXA11 | ANXA13 | ANXA2 | ANXA2P1 | ANXA2P2 | ANXA2P3 | ANXA2R | ANXA2R-AS1 | ANXA2R-OT1 | ANXA3 | ANXA4 | ANXA5 | ANXA6 | ANXA7 | ANXA8 | ANXA8L1 | ANXA8L2 | ANXA9 | AOAH | AOC1 | AOC2 | AOC3 | AOC4P | AOPEP | AOX1 | AOX2P | AP-1 Transcription Factor Complex | AP1AR | AP1B1 | AP1B1P1 | AP1G1 | AP1G2 | AP1M1 | AP1M2 | AP1S1 | AP1S2 | AP1S3 | AP2A1 | AP2A2 | AP2B1 | AP2M1 | AP2S1 | AP3B1 | AP3B2 | AP3D1 | AP3M1 | AP3M2 | AP3S1 | AP3S2 | AP4B1 | AP4B1-AS1 | AP4E1 | AP4M1 | AP4S1 | AP5B1 | AP5M1 | AP5S1 | AP5Z1 | APAF1 | APBA1 | APBA2 | APBA3 | APBB1 | APBB1IP | APBB2 | APBB3 | APC | APC2 | APCDD1 | APCDD1L | APCDD1L-DT | APCS | APEH | APELA